Karp Daniel Insider Trades

Insider Trading History

Track insider trading activity for Karp Daniel. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $180k 13,432 shares
Last Trade
Mar 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 18,053 shares
$5.99
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $960k 71,652 shares
Last Trade
Mar 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 18,053 shares
$5.99
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $932k 69,547 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.3k 5,659 shares
$5.70
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $1.34M 100,166 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$600k 100,166 shares
$5.99
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $766k 57,153 shares
Last Trade
Mar 29, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26k 4,446 shares
$5.84
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $815k 60,853 shares
Last Trade
Mar 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$82.8k 14,184 shares
$5.84
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $190k 14,185 shares
Last Trade
Mar 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$82.8k 14,184 shares
$5.84
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $625k 46,669 shares
Last Trade
May 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.8k 3,500 shares
$8.24
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $1.33M 99,009 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 99,009 shares
$14.89
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $578k 43,169 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$158k 10,870 shares
$14.51
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $0 0 shares
Last Trade
Mar 29, 2025 Sale
$617k 42,553 shares
$14.51
$13.40
Organon
Organon OGN
Executive Vp, Corp. Dev.
Holding Value $259k 19,362 shares
Last Trade
Sep 09, 2024 Sale
$585k 28,996 shares
$20.18
$13.40
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $818k 4,174 shares
Last Trade
Feb 12, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$374k 1,126 shares
$331.76
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $1.18M 6,030 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 6,030 shares
$331.76
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $1.04M 5,300 shares
Last Trade
Feb 12, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 960 shares
$331.76
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $240k 1,224 shares
Last Trade
Feb 12, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 960 shares
$331.76
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $182k 930 shares
Last Trade
Feb 12, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$97.5k 294 shares
$331.76
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $51.7k 264 shares
Last Trade
Jul 02, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.7k 58 shares
$236.37
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $63.1k 322 shares
Last Trade
Jul 02, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46.3k 196 shares
$236.37
$195.96
Biogen
Biogen BIIB
Evp, Corporate Development
Holding Value $230k 1,174 shares
Last Trade
Jul 02, 2019 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$92.2k 390 shares
$236.37
$195.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up